Hypermutated tumours in the era of immunotherapy: The paradigm of personalised medicine
- 25 August 2017
- journal article
- review article
- Published by Elsevier BV in European Journal of Cancer
- Vol. 84, 290-303
- https://doi.org/10.1016/j.ejca.2017.07.026
Abstract
No abstract availableFunding Information
- Inca (2016-144)
- DGOS-INSERM (6043)
This publication has 99 references indexed in Scilit:
- Signatures of mutational processes in human cancerNature, 2013
- Integrated genomic characterization of endometrial carcinomaNature, 2013
- Germline and somatic polymerase ϵ and δ mutations define a new class of hypermutated colorectal and endometrial cancersThe Journal of Pathology, 2013
- Comprehensive molecular characterization of human colon and rectal cancerNature, 2012
- Rapid Development of Colorectal Neoplasia in Patients With Lynch SyndromeClinical Gastroenterology and Hepatology, 2011
- Frequency of mismatch repair deficiency in ovarian cancer: a systematic review This article is a US Government work and, as such, is in the public domain of the United States of America.International Journal of Cancer, 2010
- Lethal Mutagenesis: Targeting the Mutator Phenotype in CancerSeminars in Cancer Biology, 2010
- Mutator phenotypes due to DNA replication infidelitySeminars in Cancer Biology, 2010
- Comprehensive genomic characterization defines human glioblastoma genes and core pathwaysNature, 2008
- The risk of extra‐colonic, extra‐endometrial cancer in the Lynch syndromeInternational Journal of Cancer, 2008